5. Amy Miskimon Goss, Barbara A Gower, Taraneh Soleymani, Mariah Stewart, and Kevin Fontaine, «Effects of an Egg-Based, Carbohydrate-Restricted Diet on Body Composition, Fat Distribution, and Metabolic Health in Older Adults with Obesity: Preliminary Results from a Randomized Controlled Trial», FASEB Journal (April 2017).
6. Sarah J. Hallberg, A. L. McKenzie, P. T. Williams, et al., «Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study», Diabetes Therapy 9 (April 2018): 583–612.
7. Jeff S. Volek, S. D. Phinney, C. E. Forsythe, et al., «Carbohydrate Restriction Has a More Favorable Impact on the Metabolic Syndrome than a Low Fat Diet», Lipids 44 (April 2009): 297–309.
8. P. Sumithran, L. A. Prendergast, E. Delbridge, et al., «Ketosis and Appetite-Mediating Nutrients and Hormones after Weight Loss», European Journal of Clinical Nutrition 67 (July 2013): 759–764.
9. Antonio Paoli, G. Bosco, E. M. Camporesi, and D. Mangar, «Ketosis, Ketogenic Diet and Food Intake Control: A Complex Relationship», Frontiers in Psychology 6 (Febru– ary 2015).
10. Priya Sumithran, Luke A. Prendergast, Elizabeth Delbridge, «Long-Term Persistence of Hormonal Adaptations to Weight Loss», New England Journal of Medicine 365 (Octo– ber 2011): 1597–1604.
11. Liu Lin Thio, «Hypothalamic Hormones and Metabolism», Epilepsy Research 100 (July 2012): 245–251.
12. Pam Harrison, «Almost Half the US Population Has Diabetes or Its Precursor», Medscape, July 19, 2017, https: / / www.medscape.com / viewarticle / 883132.
13. Thomas Reinehr, «Type 2 Diabetes Mellitus in Children and Adolescents», World Journal of Diabetes 4 (December 2013): 270–281.
14. Elizabeth J. Mayer-Davis, Jean M. Lawrence, Dana Dabelea, et al., «Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012», New England Journal of Medicine 376 (April 2017): 1419–1429.
15. I. Partsalaki, A. Karvela, and B. Spiliotis, «Metabolic Impact of a Ketogenic Diet Compared to a Hypocaloric Diet in Obese Children and Adolescents», Journal of Pediatric Endocrinology and Metabolism 25 (2012): 697–704.
16. University of California San Francisco, Sugar Science, «How Much Is Too Much?» http: / / sugarscience.ucsf.edu / the-growing-concern-of-overconsumption.htm l#.W3sglJNKhEI.
17. Sanjay Basu, Paula Yoffe, Nancy Hills, and Robert H. Lustig, «The Relationship of Sugar to Population-Level Diabetes Prevalence: An Economic Analysis of Repeated Cross-Sectional Data», PLOS One 8 (February 2013).
18. Alison B. Evert, Jackie L. Boucher, Marjorie Cypress, et al., «Nutrition Therapy Recommendations for the Management of Adults with Diabetes», Diabetes Care 36 (November 2013).
19. H. M. Dashti, Thazhumpal C. Mathew, Talib Hussein, et al., «Long-Term Effects of a Ketogenic Diet in Obese Patients», Experimental & Clinical Cardiology 9 (Fall 2004): 200–205.
20. M. P. St-Onge and P. J. Jones, «Greater Rise in Fat Oxidation with Medium-Chain Tri-glyceride Consumption Relative to Long-Chain Triglyceride Is Associated with Lower Initial Body Weight and Greater Loss of Subcutaneous Adipose Tissue», International Journal of Obesity and Related Metabolic Disorders 27 (December 2003): 1565–1571.
21. R. A. Anderson, N. Cheng, N. A. Bryden, et al., «Elevated Intakes of Supplemental Chromium Improve Glucose and Insulin Variables in Individuals with Type 2 Diabetes», Diabetes 46 (November 1997): 1786–1791.
22. T. Kim, J. Davis, A. J. Zhang, X. He, and S. T. Mathews, «Curcumin Activates AMPK and Suppresses Gluconeogenic Gene Expression in Hepatoma Cells», Biochemical and Biophysical Research Communications 388 (October 2009): 377–382.
23. Nafiseh Khandouzi, F. Shidfar, A. Rajab, T. Rahideh, P. Hosseini, and M. Mir Taheri, «The Effects of Ginger on Fasting Blood Sugar, Hemoglobin A1c, Apolipoprotein B, Apolipoprotein A-I and Malondialdehyde in Type 2 Diabetic Patients», Iranian Journal of Pharmaceutical Research 14 (Winter 2015): 131–140.
24. L. Nogara, N. Naber, E. Pate, M. Canton, C. Reggiani, and R. Cooke, «Piperine’s Mitigation of Obesity and Diabetes Can Be Explained by Its Up-Regulation of the Metabolic Rate of Resting Muscle», Proceedings of the National Academy of Sciences 113 (November 2016): 13009–13014.
ГЛАВА 8.
Ваш мозг на кето
1. Maciej Gasior, Michael A. Rogawski, and Adam L. Hartman, «Neuroprotective and Disease-Modifying Effects of the Ketogenic Diet», Behavioral Pharmacology 17 (Sep– tember 2006): 431–439.
2. Alzheimer’s Association, «2018 Alzheimer’s Disease Facts and Figures», https: / / www.alz.org / media / Documents / alzheimers-facts-and-figures-infographic.pdf.
3. Ibid.
4. World Health Organization, «Dementia: Key Facts», http: / / www.who.int / news-room / fact-sheets / detail / dementia.
5. Fanfan Zheng, L. Yan, Z. Yang, B. Zhong, W. Xie, «HbA1c, Diabetes and Cognitive Decline: The English Longitudinal Study of Aging», Diabetologia 61 (April 2018): 839–848.
6. Yang An, V. R. Varma, S. Varma, et al., «Evidence for Brain Glucose Dysregulation in Alzheimer’s Disease», Alzheimer’s & Dementia 14 (March 2018): 318–329.
7. Ingrid Van der Auwera, Stefaan Wera, Fred Van Leuven, and Samuel T. Henderson, «A Ketogenic Diet Reduces Amyloid Beta 40 and 42 in a Mouse Model of Alzheimer’s Disease», Nutrition & Metabolism 2 (October 2005).
8. Matthew K. Taylor et al., «Feasibility and Efficacy Data from a Ketogenic Diet Intervention in Alzheimer’s Disease», Alzheimer’s & Dementia: Translation Research & Clinical Interventions 4 (2018): 28–36.
9. Rosebud O. Roberts, L. A. Roberts, Y. E. Geda, et al., «Relative Intake of Macronu– trients Impacts Risk of Mild Cognitive Impairment or Dementia», Journal of Alzheimer’s Disease 32 (January 2012): 329–339.
10. Steven C. Vlad et al., «Protective Effects of NSAIDs on the Development of Alzheimer Disease», Neurology 70 (May 2008): 1672–1677.
11. Markus Bock, Andreas Michalsen, and Friedemann Paul, «Ketogenic Diet and Prolonged Fasting Improve Health-Related Quality of Life and Lipid Profiles in Multiple Sclerosis – A Randomized Controlled Trial» (Conference Paper, ECTRIMS 2015, Barcelona, October 2015).
12. T. E. Cullingford, «The Ketogenic Diet; Fatty Acids, Fatty Acid-Activated Receptors and Neurological Disorders», Prostaglandins, Leukotrines and Essential Fatty Acids 70 (March 2004): 253–264.
13. Mithu Storoni and Gordon T. Plant, «The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis», Multiple Sclerosis International (December 2015).
